Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants
- PMID: 35938726
- PMCID: PMC9426414
- DOI: 10.1128/mbio.01944-22
Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants
Abstract
The human upper respiratory tract, specifically the nasopharyngeal epithelium, is the entry portal and primary infection site of respiratory viruses. Productive infection of SARS-CoV-2 in the nasal epithelium constitutes the cellular basis of viral pathogenesis and transmissibility. Yet a robust and well-characterized in vitro model of the nasal epithelium remained elusive. Here we report an organoid culture system of the nasal epithelium. We derived nasal organoids from easily accessible nasal epithelial cells with a perfect establishment rate. The derived nasal organoids were consecutively passaged for over 6 months. We then established differentiation protocols to generate 3-dimensional differentiated nasal organoids and organoid monolayers of 2-dimensional format that faithfully simulate the nasal epithelium. Moreover, when differentiated under a slightly acidic pH, the nasal organoid monolayers represented the optimal correlate of the native nasal epithelium for modeling the high infectivity of SARS-CoV-2, superior to all existing organoid models. Notably, the differentiated nasal organoid monolayers accurately recapitulated higher infectivity and replicative fitness of the Omicron variant than the prior variants. SARS-CoV-2, especially the more transmissible Delta and Omicron variants, destroyed ciliated cells and disassembled tight junctions, thereby facilitating virus spread and transmission. In conclusion, we establish a robust organoid culture system of the human nasal epithelium for modeling upper respiratory infections and provide a physiologically-relevant model for assessing the infectivity of SARS-CoV-2 emerging variants. IMPORTANCE An in vitro model of the nasal epithelium is imperative for understanding cell biology and virus-host interaction in the human upper respiratory tract. Here we report an organoid culture system of the nasal epithelium. Nasal organoids were derived from readily accessible nasal epithelial cells with perfect efficiency and stably expanded for more than 6 months. The long-term expandable nasal organoids were induced maturation into differentiated nasal organoids that morphologically and functionally simulate the nasal epithelium. The differentiated nasal organoids adequately recapitulated the higher infectivity and replicative fitness of SARS-CoV-2 emerging variants than the ancestral strain and revealed viral pathogenesis such as ciliary damage and tight junction disruption. Overall, we established a human nasal organoid culture system that enables a highly efficient reconstruction and stable expansion of the human nasal epithelium in culture plates, thus providing a facile and robust tool in the toolbox of microbiologists.
Keywords: SARS-CoV-2; airway organoids; ciliary damage; nasal organoids; tight junction.
Conflict of interest statement
The authors declare a conflict of interest. J.Z., K.Y.Y., M.C.C., and C.L. are listed as inventors on the patent of airway organoids (publication No: US-2021-0207081-A1). J.Z., M.C.C., C.L., and K.Y.Y. are listed as inventors on the provisional patent of nasal organoids (US application No: 63/358,795) describing the methods in this paper. All other authors declare no competing interests.
Figures





Similar articles
-
Apical-Out Human Airway Organoids Modeling SARS-CoV-2 Infection.Viruses. 2023 May 14;15(5):1166. doi: 10.3390/v15051166. Viruses. 2023. PMID: 37243252 Free PMC article.
-
A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant.Cell Discov. 2022 Jun 17;8(1):57. doi: 10.1038/s41421-022-00422-1. Cell Discov. 2022. PMID: 35710786 Free PMC article.
-
Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection.Int J Mol Sci. 2022 Jan 13;23(2):835. doi: 10.3390/ijms23020835. Int J Mol Sci. 2022. PMID: 35055020 Free PMC article.
-
Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air.Int J Mol Sci. 2021 Jul 24;22(15):7919. doi: 10.3390/ijms22157919. Int J Mol Sci. 2021. PMID: 34360686 Free PMC article. Review.
-
Human organoid models to study SARS-CoV-2 infection.Nat Methods. 2022 Apr;19(4):418-428. doi: 10.1038/s41592-022-01453-y. Epub 2022 Apr 8. Nat Methods. 2022. PMID: 35396481 Review.
Cited by
-
Influence of cell type specific infectivity and tissue composition on SARS-CoV-2 infection dynamics within human airway epithelium.PLoS Comput Biol. 2023 Aug 11;19(8):e1011356. doi: 10.1371/journal.pcbi.1011356. eCollection 2023 Aug. PLoS Comput Biol. 2023. PMID: 37566610 Free PMC article.
-
Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants.Proc Natl Acad Sci U S A. 2023 Apr 25;120(17):e2300376120. doi: 10.1073/pnas.2300376120. Epub 2023 Apr 17. Proc Natl Acad Sci U S A. 2023. PMID: 37068258 Free PMC article.
-
Human respiratory organoids sustained reproducible propagation of human rhinovirus C and elucidation of virus-host interaction.Nat Commun. 2024 Dec 30;15(1):10772. doi: 10.1038/s41467-024-55076-2. Nat Commun. 2024. PMID: 39738014 Free PMC article.
-
A branched peptide targets virus and host to block influenza virus and rhinovirus entry.Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0002425. doi: 10.1128/aac.00024-25. Epub 2025 Jun 25. Antimicrob Agents Chemother. 2025. PMID: 40560073 Free PMC article.
-
Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract Disorders.Children (Basel). 2023 Jun 5;10(6):1020. doi: 10.3390/children10061020. Children (Basel). 2023. PMID: 37371252 Free PMC article.
References
-
- Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. 2020. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395:514–523. doi:10.1016/S0140-6736(20)30154-9. - DOI - PMC - PubMed
-
- Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus I, Research T. 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. doi:10.1056/NEJMoa2001017. - DOI - PMC - PubMed
-
- Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE, 3rd, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J. 2021. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell 184:4713–4733.e22. doi:10.1016/j.cell.2021.07.023. - DOI - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous